Analysis of Antibody Drug Conjugate Through the Characterization of Drug Antibody Ratios
Applications
| 2015 | Agilent Technologies
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Detection and Identification of Extractable Compounds from a Drug Container Closure System Using High Resolution LC/MS and Mass Profiler Software
Applications
| 2015 | Agilent Technologies
Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
Software, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Screening, Identifying, and Quantifying Potential Genotoxic Compounds Using High Resolution LC/MS
Applications
| 2015 | Agilent Technologies
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
An Integrated Workflow for the Comprehensive Analysis of Antibody‑Drug Conjugates
Applications
| 2015 | Agilent Technologies
LC/TOF, LC/HRMS, LC/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Identification and Structural Elucidation of Amlodipine Impurities Using High Resolution LC/MS and LC-MS/MS
Applications
| 2015 | Agilent Technologies
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
High Sensitivity Intact Mass Analysis of Antibodies (IgG1) Using ionKey/MS
Applications
| 2015 | Waters
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Waters
Industries
Pharma & Biopharma
LOCALIZING THE CONJUGATION SITES OF CYSTEINE-CONJUGATED ANTIBODY DRUG CONJUGATES BY IMPROVED LC-MS SUBUNIT ANALYSIS FOR ADC POSITIONAL ISOMER IDENTIFICATION
Posters
| 2015 | Waters
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Instrumentation
LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
Manufacturer
Waters
Industries
Pharma & Biopharma
A COMBINED WORKFLOW FOR IN-DEPTH CHARACTERIZATION OF CYSTEINE-CONJUGATED ANTIBODY DRUG CONJUGATES